Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: May 8, 2025
Date Accepted: Feb 9, 2026

The final, peer-reviewed published version of this preprint can be found here:

A Chronic Pain Self-Management Mobile App (Dolodoc): Cross-Sectional Acceptability Study

Guebey J, Gosetto L, Rehberg B, Lovis C, Ehrler F, Molinard-Chenu A

A Chronic Pain Self-Management Mobile App (Dolodoc): Cross-Sectional Acceptability Study

JMIR Hum Factors 2026;13:e77163

DOI: 10.2196/77163

PMID: 42134789

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Dolodoc, a mobile application for the self-management of chronic pain: Acceptability and usability study

  • Julie Guebey; 
  • Laetitia Gosetto; 
  • Benno Rehberg; 
  • Christian Lovis; 
  • Frederic Ehrler; 
  • Aude Molinard-Chenu

ABSTRACT

Background:

Approximately 19% of adults in Europe are affected by chronic pain, which reduces quality of life. Pain management apps offer a promising solution for self-management, but users engagement and adherence can be a limitation to their clinical impact. User experience design and studies play an important role in optimizing usability and long-term adoption of digital health interventions.

Objective:

This study aims to evaluate the user experience of Dolodoc, a mobile application for chronic pain self-management, using a mixed-methods approach that evaluates acceptability through a content quality survey and examines usability by analyzing overall usage patterns.

Methods:

A cross-sectional acceptability study was conducted among chronic pain patients recruited from the Geneva University Hospitals pain center and through snowball sampling. Participants rated 84 evidence-based self-management strategies using a five-point Likert scale based on 5 acceptability criterias: understandability, motivation, feasibility, relevance, and alignment with the related quality-of-life dimension. Usability was assessed through usage metrics that were collected over six months using Piwik PRO analytics to observe the usage behaviors of real-world Dolodoc users.

Results:

In the acceptability study, a total of 33 participants rated the self-management strategies positively across all dimensions. On a scale from -2 to 2, the strategies were well understood (mean = 1,47), motivational (1.12), feasible(1.01), relevant (0.99), and aligned with the dimensions (1.33). The usability study demonstrated that 60% of patients used Dolodoc only once, indicating that long-term adherence remains a challenge. Within Dolodoc, pain tracking, useful links and medication logging were the most actively used features.

Conclusions:

This study highlights the gap between acceptability and long-term adherence to mHealth solutions. Improving personalization and accessibility could increase user engagement and long-term adherence. Future iterations of the app should incorporate tailored interventions and real-time feedback mechanisms. In addition, taking advantage of a digital navigation follow-up could facilitate user adoption and sustained engagement.


 Citation

Please cite as:

Guebey J, Gosetto L, Rehberg B, Lovis C, Ehrler F, Molinard-Chenu A

A Chronic Pain Self-Management Mobile App (Dolodoc): Cross-Sectional Acceptability Study

JMIR Hum Factors 2026;13:e77163

DOI: 10.2196/77163

PMID: 42134789

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.